Martin Ruttledge

2.2k total citations
27 papers, 1.6k citations indexed

About

Martin Ruttledge is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Martin Ruttledge has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 8 papers in Pathology and Forensic Medicine and 8 papers in Epidemiology. Recurrent topics in Martin Ruttledge's work include Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Migraine and Headache Studies (6 papers). Martin Ruttledge is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Migraine and Headache Studies (6 papers). Martin Ruttledge collaborates with scholars based in Sweden, Canada and United States. Martin Ruttledge's co-authors include Jan P. Dumanski, Guy A. Rouleau, Magnus Nordenskjöld, V. Peter Collins, Catherine M. Phelan, Olivier Delattre, Gilles Thomas, P. Merel, Fei‐Yu Han and Ya‐Gang Xie and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Ruttledge

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Ruttledge Sweden 16 922 711 427 299 244 27 1.6k
O. Dubourg France 33 668 0.7× 993 1.4× 985 2.3× 559 1.9× 144 0.6× 70 3.0k
Pierre Labauge France 25 2.1k 2.2× 218 0.3× 302 0.7× 295 1.0× 226 0.9× 51 2.7k
Mitsuhiro Hara Japan 22 745 0.8× 340 0.5× 197 0.5× 171 0.6× 159 0.7× 89 1.9k
H. -D. Herrmann Germany 25 864 0.9× 420 0.6× 295 0.7× 124 0.4× 215 0.9× 97 2.0k
Iwao Takeshita Japan 27 697 0.8× 400 0.6× 515 1.2× 140 0.5× 126 0.5× 93 2.0k
Allan E. Rubenstein United States 17 658 0.7× 387 0.5× 250 0.6× 181 0.6× 95 0.4× 34 1.0k
J F Pellissier France 20 588 0.6× 217 0.3× 438 1.0× 196 0.7× 98 0.4× 57 1.6k
Donald Seyfried United States 21 983 1.1× 394 0.6× 335 0.8× 90 0.3× 61 0.3× 35 1.5k
S. Tokiguchi Japan 19 568 0.6× 94 0.1× 546 1.3× 170 0.6× 81 0.3× 50 1.5k
Sigrid Tinschert Germany 31 860 0.9× 351 0.5× 1.3k 3.1× 596 2.0× 340 1.4× 94 3.1k

Countries citing papers authored by Martin Ruttledge

Since Specialization
Citations

This map shows the geographic impact of Martin Ruttledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ruttledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ruttledge more than expected).

Fields of papers citing papers by Martin Ruttledge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Ruttledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ruttledge. The network helps show where Martin Ruttledge may publish in the future.

Co-authorship network of co-authors of Martin Ruttledge

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Ruttledge. A scholar is included among the top collaborators of Martin Ruttledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Ruttledge. Martin Ruttledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ray, Jason C., Penelope J. Allen, Julian J. Bosco, et al.. (2021). Inflammatory complications of CGRP monoclonal antibodies: a case series. The Journal of Headache and Pain. 22(1). 121–121. 40 indexed citations
3.
Craven, Audrey, et al.. (2020). Migraine and Headache Care in the Republic of Ireland: History and a Vision for the Future Influenced by the COVID‐19 Pandemic. Headache The Journal of Head and Face Pain. 60(10). 2665–2668. 1 indexed citations
4.
Nesbitt, Alexander, et al.. (2015). Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 84(12). 1249–1253. 111 indexed citations
5.
Ruttledge, Martin & Guy A. Rouleau. (2005). Role of the neurofibromatosis Type 2 gene in the development of tumors of the nervous system. Neurosurgical FOCUS. 19(5). 1–5. 7 indexed citations
6.
Devaney, James, et al.. (2003). Cystic fibrosis mutation frequencies in an Irish population. Clinical Genetics. 63(2). 121–125. 15 indexed citations
7.
Phelan, Catherine M., Catharina Larsson, Stephen Baird, et al.. (1996). The Human Mammary-Derived Growth Inhibitor (MDGI) Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors. Genomics. 34(1). 63–68. 29 indexed citations
8.
Phelan, Catherine M., Barbara Weber, Peter Devilee, et al.. (1996). Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genetics. 12(3). 309–311. 155 indexed citations
9.
MacCollin, Mia, Kevin Davis, Nancy Braverman, et al.. (1996). A point mutation associated with a severe phenotype of neurofibromatosis 2. Annals of Neurology. 40(3). 440–445. 10 indexed citations
10.
Phelan, Catherine M., Catharina Larsson, Stephen Baird, et al.. (1996). The Human Mammary-Derived Growth Inhibitor (MDGI) Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors. Genomics. 36(2). 377–377.
11.
Peyrard, Myriam, Ingegerd Fransson, Ya‐Gang Xie, et al.. (1994). Characterization of a new member of the human /-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Human Molecular Genetics. 3(8). 1393–1399. 81 indexed citations
12.
Ruttledge, Martin, Ya‐Gang Xie, Fei‐Yu Han, et al.. (1994). Physical Mapping of the NF2/Meningioma Region on Human Chromosome 22q12. Genomics. 19(1). 52–59. 11 indexed citations
13.
Lindblom, Annika, Martin Ruttledge, V. Peter Collins, Magnus Nordenskjöld, & Jan P. Dumanski. (1994). Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. International Journal of Cancer. 56(3). 354–357. 79 indexed citations
14.
Ruttledge, Martin, Marylène Rousseau, Marc Sanson, et al.. (1994). The neurofibromatosis type 2 gene is inactivated in schwannomas. Human Molecular Genetics. 3(1). 147–151. 118 indexed citations
15.
Ruttledge, Martin, Catherine M. Phelan, P. Merel, et al.. (1994). Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genetics. 6(2). 180–184. 433 indexed citations
16.
Sanson, Marc, Claude Marineau, Chantal Desmaze, et al.. (1993). Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Human Molecular Genetics. 2(8). 1215–1220. 47 indexed citations
17.
Han, Fei‐Yu, Martin Ruttledge, Ingegerd Fransson, et al.. (1993). Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12. Human Molecular Genetics. 2(9). 1361–1368. 22 indexed citations
18.
Narod, Steven A., Dilys M. Parry, Jillian S. Parboosingh, et al.. (1992). Neurofibromatosis type 2 appears to be a genetically homogeneous disease.. Europe PMC (PubMed Central). 51(3). 486–96. 41 indexed citations
19.
Dumanski, Jan P., A.H.M. Geurts van Kessel, Martin Ruttledge, et al.. (1990). Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter. Human Genetics. 84(3). 219–222. 18 indexed citations
20.
Dumanski, Jan P., Martin Ruttledge, & Siraj Datta. (1988). Rapid minipreparations of bacteriophage   DNA. Nucleic Acids Research. 16(18). 9044–9044. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Dubourg Breakdown of academic impact, for papers by Pierre Labauge Breakdown of academic impact, for papers by Mitsuhiro Hara Breakdown of academic impact, for papers by H. -D. Herrmann Breakdown of academic impact, for papers by Iwao Takeshita Breakdown of academic impact, for papers by Allan E. Rubenstein Breakdown of academic impact, for papers by J F Pellissier Breakdown of academic impact, for papers by Donald Seyfried Breakdown of academic impact, for papers by S. Tokiguchi Breakdown of academic impact, for papers by Sigrid Tinschert
Rankless by CCL
2026